16 results on '"Del Prete S"'
Search Results
2. The Ischia island flash flood of November 2009 (Italy): Phenomenon analysis and flood hazard
3. C40 - PerTe: efficacy and safety of pertuzumab in “real life setting” for the neoadjuvant treatment of HER2-positive breast cancer patients
4. Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs)
5. Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study
6. Anemia may influence the outcome of patients undergoing neo-adjuvant treatment of rectal cancer
7. Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study
8. P.10.1 REACTIVATION OF HEPATITIS B VIRUS IN CANCER PATIENTS TREATED WITH CHEMOTHERAPY FOR SOLID TUMORS. IS THE PROPHYLAXIS REALLY REQUIRED?
9. P315 Acceptance and adherence with oral endocrine therapy in women with metastatic breast cancer: ExaCampania group study
10. P273 Non-pegylated liposomal doxorubicin in combination with cyclophosphamide and docetaxel as adjuvant therapy for women with high-risk breast cancer. Safety, quality of life, and efficacy analysis of TMC protocol
11. 9173 Metronomic antiangiogenetic biochemotherapy of non-small cell lung cancer patients with fractioned cisplatinum, oral etoposide and bevacizumab: phase IB/II study
12. Bevacizumab + folfiri as first-line treatment in advanced colorectal cancer (ACC): A multicenter phase II study of the Gruppo Oncologico dell’ Italia Meridionale (prot. GOIM 2601)
13. Sorafenib plus long-acting octreotide in advanced hepatocellular carcinoma. Preliminary results of a multicenter ongoing study
14. Metronomic oral vinorelbine and temozolomide, after whole brain radiotherapy, for the treatment of breast cancer patients with brain metastasis. A phase II study
15. A Phase II study of IncelTM (biricodar, VX-710) in combination with paclitaxel in women with advanced breast cancer refractory to paclitaxel
16. DO THE HEPATITIS ANTIGENS CROSS THE PLACENTA ?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.